Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells...
News
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
BioAdaptives, Inc. ASSESS BODY FAT CONTENT FROM ONE PICTURE The first-ever approach resulted from validating studies over a single lateral...
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands...
Jack Ride 15 Brings Community Together to End the Youth Mental Health Emergency
Jack.org invites you to join Canada’s Ride for Youth Mental Health and support life-changing youth mental health programs in communities...
ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis
Up to 40% of women with triple negative breast cancer (TNBC) experience metastasis to their brain, which affects physical function,...
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
CERVAI™ Brain Health CERVAI™ Brain Health TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”)...
Venus Concept Launches Venus Prime
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical...
Manitoba Harvest Hemp Foods Celebrates a Decade of B Corp Certification With a Score of 100 Points
Manitoba Harvest Hemp Foods Scores 100 Points for B Corp Certification Image taken for Manitoba Harvest's Regenerative Hemp Hearts Products...
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the...
Mary Beth DeLena Joins PepGen as General Counsel and Secretary
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...
Gritstone bio to Participate in Upcoming Investor Conference
EMERYVILLE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop...
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Financing was led by New Enterprise Associates (NEA) and closed with additional new investor Atlas Venture and continued investment by...
MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Samsung Bioepis Releases First Quarter 2024 US Biosimilar Market Report
Report highlights latest biosimilar pricing and market share status, including state of the adalimumab marketBiosimilar Deep Dive section illustrates patient...
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation...
Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd
The Combined Company Is Expected To Trade On Nasdaq Post-Closing Under A New Ticker SymbolMediforum is a leading biotechnology company...
Arvinas Appoints Jared Freedberg as General Counsel
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4)NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose...
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company...
Psyched Wellness Provides Update on Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - January 17, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...